Patents by Inventor Martin P. Debreczeny

Martin P. Debreczeny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173111
    Abstract: The present disclosure relates to systems and methods for determining the renal glomerular filtration rate or assessing the renal function in a patient in need thereof. The system includes a computing device, a power supply, one or more sensors, and at least one tracer agent that fluoresces when exposed to electromagnetic radiation. The electromagnetic radiation is detected using the sensors, and the rate in which the fluorescence decreases in the patient is used to calculate the renal glomerular filtration rate in the patient.
    Type: Application
    Filed: January 31, 2023
    Publication date: June 8, 2023
    Inventors: Martin P. Debreczeny, Raghavan Rajagopalan, Richard B. Dorshow, William L. Neumann, Thomas E. Rogers
  • Publication number: 20230158175
    Abstract: A method for determining a glomerular filtration rate (GFR) in a patient includes administering to said patient a compound of Formula I and transdermally measuring spectral energy emitted by the compound of Formula I over a measurement time window. The spectral energy is emitted by the compound of Formula I in response to electromagnetic radiation delivered to the compound of Formula I. The method also includes determining the GFR in said patient based on the measured spectral energy emitted by the compound of Formula I over the measurement time window by fitting an exponential function to the spectral energy as a function of time or a linear function to the log of the spectral energy as a function of time to calculate a rate constant associated with renal clearance over the measurement time window and directly related to the GFR normalized to a body size metric of the patient.
    Type: Application
    Filed: January 25, 2023
    Publication date: May 25, 2023
    Inventors: Raghavan Rajagopalan, Richard B. Dorshow, William L. Neumann, Thomas E. Rogers, Martin P. Debreczeny
  • Patent number: 11602570
    Abstract: The present disclosure relates to systems and methods for determining the renal glomerular filtration rate or assessing the renal function in a patient in need thereof. The system includes a computing device, a power supply, one or more sensors, and at least one tracer agent that fluoresces when exposed to electromagnetic radiation. The electromagnetic radiation is detected using the sensors, and the rate in which the fluorescence decreases in the patient is used to calculate the renal glomerular filtration rate in the patient.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: March 14, 2023
    Assignee: MediBeacon Inc.
    Inventors: Martin P. Debreczeny, Raghavan Rajagopalan, Richard B. Dorshow, William L. Neumann, Thomas E. Rogers
  • Patent number: 11590244
    Abstract: The present disclosure relates to systems and methods for determining the renal glomerular filtration rate or assessing the renal function in a patient in need thereof. The method includes administering a pyrazine compound of Formula I to a patient and monitoring the rate in which the kidneys of the patient eliminate the pyrazine from the systemic circulation of the patient. The pyrazine compound fluoresces when exposed to electromagnetic radiation which is detected using one or more sensors. The rate in which the fluorescence decreases in the patient is used to calculate the renal glomerular filtration rate in the patient.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: February 28, 2023
    Assignee: MediBeacon Inc.
    Inventors: Raghavan Rajagopalan, Richard B. Dorshow, William L. Neumann, Thomas E. Rogers, Martin P. Debreczeny
  • Patent number: 10989645
    Abstract: This invention provides, e.g., devices for detection of particle concentrations in a vessel in real time from outside the vessel. The device is attached to the vessel so that light from an optic fiber enters a media of the vessel, is scattered by the particles, and the scattered light received by a second optic fiber. The received light is transmitted to a detector, generating a signal to a processor for determination of a particle concentration.
    Type: Grant
    Filed: August 10, 2019
    Date of Patent: April 27, 2021
    Assignee: ABER INSTRUMENTS, INC.
    Inventors: Gerald P. Coleman, Martin P. Debreczeny, Jaime Romero
  • Patent number: 10952656
    Abstract: A sensor head is provided. In any of the various aspects of the invention, the sensor head has a housing enclosing at least two light sources configured to deliver light to a patient and comprising a blue LED first light source that delivers light at an excitatory wavelength and a green LED second light source, and at least one light detector configured to detect light at an emission wavelength from the patient. The sensor is useful for non-invasive monitoring of fluorescent tracers agents.
    Type: Grant
    Filed: August 24, 2020
    Date of Patent: March 23, 2021
    Assignee: MediBeacon Inc.
    Inventors: Kimberly Shultz, Kate Bechtel, Martin P. Debreczeny
  • Publication number: 20200049608
    Abstract: This invention provides, e.g., devices for detection of particle concentrations in a vessel in real time from outside the vessel. The device is attached to the vessel so that light from an optic fiber enters a media of the vessel, is scattered by the particles, and the scattered light received by a second optic fiber. The received light is transmitted to a detector, generating a signal to a processor for determination of a particle concentration.
    Type: Application
    Filed: August 10, 2019
    Publication date: February 13, 2020
    Inventors: Gerald P. Coleman, Martin P. Debreczeny, Jaime Romero
  • Patent number: 10408730
    Abstract: This invention provides methods and devices to measure particle suspension concentrations in the presence of potential interferents. Particle back-scatter readings are taken at light wavelengths that are absorbed by the medium before interacting with surrounding objects. Source-detector spacings are minimized compared to the mean absorbance path length of light, thereby maximizing the range of sensitivity to particle concentration. Discrimination against potentially interfering particles, such as bubbles, is provided by mapping the signal distribution against the central signal value and/or by the use of statistical measures with reduced dependence on outliers. The methods and devices allow accurate particle concentration readings over a wide range of concentration in environments crowded with potentially interfering objects and in the presence of variable concentrations and sizes of potentially interfering particles.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: September 10, 2019
    Inventors: Martin P. Debreczeny, Joseph A. Christman, Gerald P. Coleman
  • Publication number: 20190125901
    Abstract: The present disclosure relates to systems and methods for determining the renal glomerular filtration rate or assessing the renal function in a patient in need thereof. The system includes a computing device, a power supply, one or more sensors, and at least one tracer agent that fluoresces when exposed to electromagnetic radiation. The electromagnetic radiation is detected using the sensors, and the rate in which the fluorescence decreases in the patient is used to calculate the renal glomerular filtration rate in the patient.
    Type: Application
    Filed: October 26, 2018
    Publication date: May 2, 2019
    Inventors: Martin P. Debreczeny, Raghavan Rajagopalan, Richard B. Dorshow, William L. Neumann, Thomas E. Rogers
  • Publication number: 20190017914
    Abstract: This invention provides methods and devices to measure particle suspension concentrations in the presence of potential interferents. Particle back-scatter readings are taken at light wavelengths that are absorbed by the medium before interacting with surrounding objects. Source-detector spacings are minimized compared to the mean absorbance path length of light, thereby maximizing the range of sensitivity to particle concentration. Discrimination against potentially interfering particles, such as bubbles, is provided by mapping the signal distribution against the central signal value and/or by the use of statistical measures with reduced dependence on outliers. The methods and devices allow accurate particle concentration readings over a wide range of concentration in environments crowded with potentially interfering objects and in the presence of variable concentrations and sizes of potentially interfering particles.
    Type: Application
    Filed: July 24, 2018
    Publication date: January 17, 2019
    Inventors: Martin P. Debreczeny, Joseph A. Christman, Gerald P. Coleman
  • Patent number: 10054532
    Abstract: This invention provides methods and devices to measure particle suspension concentrations in the presence of potential interferents. Particle back-scatter readings are taken at light wavelengths that are absorbed by the medium before interacting with surrounding objects. Source-detector spacings are minimized compared to the mean absorbance path length of light, thereby maximizing the range of sensitivity to particle concentration. Discrimination against potentially interfering particles, such as bubbles, is provided by mapping the signal distribution against the central signal value and/or by the use of statistical measures with reduced dependence on outliers. The methods and devices allow accurate particle concentration readings over a wide range of concentration in environments crowded with potentially interfering objects and in the presence of variable concentrations and sizes of potentially interfering particles.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: August 21, 2018
    Inventors: Martin P. Debreczeny, Joseph A. Christman, Gerald P. Coleman
  • Publication number: 20180045635
    Abstract: This invention provides methods and devices to measure particle suspension concentrations in the presence of potential interferents. Particle back-scatter readings are taken at light wavelengths that are absorbed by the medium before interacting with surrounding objects. Source-detector spacings are minimized compared to the mean absorbance path length of light, thereby maximizing the range of sensitivity to particle concentration. Discrimination against potentially interfering particles, such as bubbles, is provided by mapping the signal distribution against the central signal value and/or by the use of statistical measures with reduced dependence on outliers. The methods and devices allow accurate particle concentration readings over a wide range of concentration in environments crowded with potentially interfering objects and in the presence of variable concentrations and sizes of potentially interfering particles.
    Type: Application
    Filed: August 17, 2017
    Publication date: February 15, 2018
    Inventors: Martin P. Debreczeny, Joseph A. Christman, Gerald P. Coleman
  • Patent number: 9752974
    Abstract: This invention provides methods and devices to measure particle suspension concentrations in the presence of potential interferents. Particle back-scatter readings are taken at light wavelengths that are absorbed by the medium before interacting with surrounding objects. Source-detector spacings are minimized compared to the mean absorbance path length of light, thereby maximizing the range of sensitivity to particle concentration. Discrimination against potentially interfering particles, such as bubbles, is provided by mapping the signal distribution against the central signal value and/or by the use of statistical measures with reduced dependence on outliers. The methods and devices allow accurate particle concentration readings over a wide range of concentration in environments crowded with potentially interfering objects and in the presence of variable concentrations and sizes of potentially interfering particles.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: September 5, 2017
    Assignee: BugLab LLC
    Inventors: Martin P. Debreczeny, Joseph A. Christman, Gerald P. Coleman
  • Publication number: 20150300938
    Abstract: This invention provides methods and devices to measure particle suspension concentrations in the presence of potential interferents. Particle back-scatter readings are taken at light wavelengths that are absorbed by the medium before interacting with surrounding objects. Source-detector spacings are minimized compared to the mean absorbance path length of light, thereby maximizing the range of sensitivity to particle concentration. Discrimination against potentially interfering particles, such as bubbles, is provided by mapping the signal distribution against the central signal value and/or by the use of statistical measures with reduced dependence on outliers. The methods and devices allow accurate particle concentration readings over a wide range of concentration in environments crowded with potentially interfering objects and in the presence of variable concentrations and sizes of potentially interfering particles.
    Type: Application
    Filed: April 20, 2015
    Publication date: October 22, 2015
    Inventors: Martin P. Debreczeny, Joseph A. Christman, Gerald P. Coleman
  • Patent number: 8989832
    Abstract: Systems, methods, and devices for obtaining consistently reproducible diagnostic measurements with a photoplethysmographic sensor are provided. In one embodiment, a method for obtaining such a diagnostic measurement includes applying a pressure between a photoplethysmographic sensor and a patient, increasing the pressure until the photoplethysmographic sensor outputs a plethysmographic waveform of minimal amplitude, decreasing the pressure by a predetermined fraction, and obtaining a diagnostic measurement using the photoplethysmographic sensor. The pressure may be applied using a pressure device that includes, for example, a clip, a wrap, an inflatable balloon or bladder, or an inflatable cuff, or any combination thereof.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: March 24, 2015
    Assignee: Covidien LP
    Inventors: Martin P. Debreczeny, Rafael Ostrowski
  • Publication number: 20150038852
    Abstract: The present invention comprises methods and systems/devices for non-invasively measuring birefringent tissues (e.g. collagen) and changes during treatment of tissue, e.g., denaturation by the application of RF energy, through linear dichroism, circular dichroism, or birefringence. The invention optionally uses polarization sensitive optical measurements to discriminate between denaturation of unidirectionally oriented strands of collagen, such as a ligament or tendon, and denaturation of planar collagen surfaces, such as the dermal layer of the skin or collagen in joint capsules.
    Type: Application
    Filed: July 14, 2014
    Publication date: February 5, 2015
    Inventors: Martin P. Debreczeny, Diana Villegas
  • Publication number: 20140073901
    Abstract: The present invention comprises methods and systems/devices for non-invasively measuring and/or altering collagen structures before, during and after treatment, e.g., by the application of RF energy, of tissues that comprise such collagen structures.
    Type: Application
    Filed: August 5, 2013
    Publication date: March 13, 2014
    Applicant: Alpha Orthopaedics, Inc.
    Inventors: Diana Villegas, Abdul Tayeb, Randal Jordheim, Martin P. Debreczeny
  • Patent number: 8603772
    Abstract: This invention provides a novel methods and devices for measurement of particle concentration or changes in particle concentration over a wide linear range. The invention comprises one or more radiation sources and one or more detectors contained in a housing which is interfaced to a medium containing particulate matter. The one or more radiation sources are directed into the medium, scattered or transmitted by the particulate matter, and then some portion of the radiation is detected by the one or more detectors. Methods for confining the measurement to a specific volume within the medium are described. Algorithms are provided for combining the signals generated by multiple source-detector pairs in a manner that results in a wide linear range of response to changes in particle concentration. In one embodiment the sensor provides non-invasive measurements of biomass in a bioreactor. In another embodiment an immersible probe design is described, which may be suited for one-time use.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: December 10, 2013
    Assignee: Bug Lab LLC
    Inventors: Martin P. Debreczeny, Jaime Romero, Ethan Petersen
  • Publication number: 20130289371
    Abstract: Systems, methods, and devices for obtaining consistently reproducible diagnostic measurements with a photoplethysmographic sensor are provided. In one embodiment, a method for obtaining such a diagnostic measurement includes applying a pressure between a photoplethysmographic sensor and a patient, increasing the pressure until the photoplethysmographic sensor outputs a plethysmographic waveform of minimal amplitude, decreasing the pressure by a predetermined fraction, and obtaining a diagnostic measurement using the photoplethysmographic sensor. The pressure may be applied using a pressure device that includes, for example, a clip, a wrap, an inflatable balloon or bladder, or an inflatable cuff, or any combination thereof.
    Type: Application
    Filed: June 20, 2013
    Publication date: October 31, 2013
    Inventors: Martin P. Debreczeny, Rafael Ostrowski
  • Patent number: 8509866
    Abstract: Devices and methods for measuring body fluid-related metric using spectrophotometry that may be used to facilitate diagnosis and therapeutic interventions aimed at restoring body fluid balance. In one embodiment, the present invention provides a device for measuring a body-tissue water content metric as a fraction of the fat-free tissue content of a patient using optical spectrophotometry. The device includes a probe housing configured to be placed near a tissue location which is being monitored; light emission optics connected to the housing and configured to direct radiation at the tissue location; light detection optics connected to the housing and configured to receive radiation from the tissue location; and a processing device configured to process radiation from the light emission optics and the light detection optics to compute the metric where the metric includes a ratio of the water content of a portion of patient's tissue in relation to the lean or fat-free content of a portion of patient's tissue.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: August 13, 2013
    Assignee: Covidien LP
    Inventors: Joseph M. Schmitt, Martin P. Debreczeny